Back to search

Article

Clinical outcomes of flomoxef versus cefmetazole in hospitalized patients with urinary tract infections: Combined retrospective analyses of two real-world databases and<i>in vitro</i>data

2024-07-17

Abstract excerpt

<h4>Background</h4> Flomoxef is active against extended-spectrum beta-lactamase (ESBL)-producing bacteria, but its clinical effectiveness has not been compared with cefmetazole. This study aimed to compare the utility of the two drugs in treating urinary tract infection (UTI) by integrating in vitro data with a retrospective analysis of two real-world databases. <h4>Methods</h4> The susceptibility rates of third-g...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c4784d42-c9dd-5761-9fa1-92f2c0a555e4
DOI
10.1101/2024.07.16.24310469
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical outcomes of flomoxef versus cefmetazole in hospitalized patients with urinary tract infections: Combined retrospective analyses of two real-world databases and<i>in vitro</i>dataDOI 10.1101/2024.07.16.24310469
Effectiveness and Safety of Cefiderocol in Clinical Practice for Treatment of Patients with Gram-Negative Bacterial Infections: US Interim Results of the PROVE StudySemantic proximity
Synergistic cefiderocol-containing antibiotic combinations active against highly drug-resistant <i>Acinetobacter baumannii</i> patient isolates with diverse resistance mechanismsSemantic proximity
Real‑world effectiveness and safety of cefiderocol in critically ill patients with MDR Gram‑negative infections: Results from a retrospective studySemantic proximity
Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.Semantic proximity
Reassessing the management of uncomplicated urinary tract infection: A retrospective analysis using machine learning causal inferenceSemantic proximity
Antibiotics and antibiotic-associated diarrhea: a real-world disproportionality study of the FDA Adverse Event Reporting System from 2004 to 2022Semantic proximity
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials.Semantic proximity
Clinical Experience of Ceftaroline-Fosamil in Gram-Positive Infective Endocarditis: A Multicenter Real-World Observational StudySemantic proximity
Safety and efficacy of intravenous doripenem for the treatment of complicated urinary tract infections and pyelonephritis.Semantic proximity
Efficacy and safety of newer antibiotics versus generic antibiotics for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia: a systematic review and meta-analysis of randomized controlled trialsSemantic proximity
Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children: A French multicenter study.Semantic proximity
Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative BacteriaSemantic proximity
Select a neighboring publication to make it the new centre.